We offer specialized testing to physicians and laboratories in different therapeutic areas by combining both molecular and proteomic diagnostics.
Our first areas of expertise include biological drug monitoring panels for inflammatory diseases like Crohn's disease, ulcerative colitis, or rheumatoid arthritis. We aim to support physicians to make the better decisions and make precision medicine a reality.
We also offer genetic diagnostics testing for different diseases, like familial hypercholesterolemia (FH), by offering the latest technologies platforms available in the market from Sanger sequencing to next-generation sequencing.
Our goal is to continue to expand our portfolio of esoteric testing in the areas where Grifols is a relevant player worldwide. This includes autoimmunity, infectious disease, neurodegenerative, and cardiovascular, and offers comprehensive panels to support our customers on their clinical decisions.